Back to results
US 2022/0054440 A1Published application
Substantially sodium free diclofenac potassium oral solutions
AssigneeAPR Applied Pharma Research S.A.
InventorsGiorgio REINER, Alberto REINER, Paola MAFFEI
Life of this patent
Estimating the term…
Abstract
Provided are orally formulations of diclofenac potassium with improved stability in response to cold conditions, and excellent taste and palatability.
Claims21
A liquid pharmaceutical composition for oral use comprising:
- a) diclofenac potassium salt in an amount from 3.5 to 20% (w/v) with respect to the volume of the composition;
- and
- b) potassium bicarbonate in an amount from 2.0 to 10.0% (w/v) with respect to the volume of the composition;
- wherein sodium ions are absent or present in said composition in an amount of up to 0.05% (w/v) with respect to the volume of the composition.
1 more element
A liquid oral pharmaceutical composition comprising:
- a) about 5 weight parts diclofenac potassium,
- b) about 30 weight parts ethyl alcohol,
- c) about 20 weight parts glycerol,
- d) about 2.5 weight parts potassium hydrogen carbonate,
- e) about 0.5 weight parts sucralose;
- and
- f) about 42.9 weight parts water.
4 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.